Mira Pharmaceuticals Inc (MIRA) Stock: What the Analysts are Saying
The stock has a 36-month beta value of 4.31. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as
The stock has a 36-month beta value of 4.31. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as
Additionally, the 36-month beta value for MIRA is 4.38. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0
In the past week, MIRA stock has gone down by -15.64%, with a monthly gain of 158.42% and a quarterly surge of 171.76%. The volatility
Mira Pharmaceuticals Inc (NASDAQ: MIRA) has seen a decline in its stock price by -5.24 in relation to its previous close of 2.10. However, the
Mira Pharmaceuticals Inc (NASDAQ: MIRA) has experienced a decline in its stock price by -15.50 compared to its previous closing price of 2.71. However, the
There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,”
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.